• (S)-(+)-Dimethindene maleate: Protocols for M2 Antagonism St

  2026-05-25

  (S)-(+)-Dimethindene maleate provides a selective tool for blocking the muscarinic acetylcholine M2 receptor and H1 histamine receptor in autonomic regulation, cardiovascular, and respiratory system research. Its well-defined solubility and storage profile enable reproducible experimental setups, but its use is strictly limited to non-clinical, scientific contexts and is not recommended for diagnostic or therapeutic applications.

• CTCF Maintains Centromere Integrity and Mitotic Fidelity in

  2026-05-24

  This study demonstrates that the chromatin architectural protein CTCF is essential for maintaining centromere structure and ensuring accurate chromosome segregation during mitosis. Rapid, inducible depletion of CTCF reveals its distinct role in safeguarding mitotic fidelity and post-mitotic nuclear morphology, with implications for understanding chromosome alignment defects relevant in cancer research.

• In Vitro Metrics for Evaluating Wee1 Inhibitors in Cancer Re

  2026-05-23

  Schwartz’s dissertation critically examines how different in vitro viability metrics—relative and fractional viability—capture distinct aspects of anti-cancer drug response, revealing that most agents, including checkpoint inhibitors, induce proliferation arrest and cell death with variable kinetics. These insights inform the optimal assessment and deployment of molecules like MK-1775 (Wee1 kinase inhibitor) in preclinical research, particularly in p53-deficient tumor contexts.

• Cyclosporin A in Bench Research: Protocols, Use Cases & Trou

  2026-05-22

  Cyclosporin A is a gold-standard cyclophilin inhibitor for immunosuppression, apoptosis, and viral entry studies. This article delivers actionable protocol insights, workflow enhancements, and troubleshooting strategies to help researchers achieve robust, reproducible results with APExBIO’s Cyclosporin A.

• ATRX Deficiency Sensitizes Glioma to RTK and PDGFR Inhibitor

  2026-05-22

  The reference study reveals that high-grade glioma cells lacking ATRX are significantly more sensitive to receptor tyrosine kinase (RTK) and PDGFR inhibitors, highlighting a potential biomarker for therapeutic stratification. This finding suggests that ATRX status should be considered in clinical trial design and may inform more personalized treatment approaches for aggressive gliomas.

• CCK-8: Precision Cell Health Quantification for Liver Injury

  2026-05-21

  This thought-leadership article explores the mechanistic and translational advantages of the Cell Counting Kit-8 (CCK-8) for in vitro modeling of liver injury, drawing on cutting-edge research into deoxynivalenol-induced hepatotoxicity and the molecular interplay between mitophagy and cytoprotective defense. It contextualizes CCK-8’s unique position in the competitive landscape, provides protocol parameters, and outlines future directions for translational researchers.

• Bile Acid Metabolism Subtypes Reveal Key CRC Immune Markers

  2026-05-21

  Feng et al. (2026) introduced a novel transcriptomic subtyping of colorectal cancer (CRC) based on bile acid metabolism, identifying CLCA1, UGT2A3, and ZG16 as markers linked to immune dysfunction and prognosis. Their integrative approach offers new avenues for understanding tumor immune microenvironment modulation and potential biomarker-driven patient stratification.

• Cinoxacin’s Antibacterial Benchmark: Findings from In Vitro

  2026-05-20

  This article analyzes the seminal in vitro study on Cinoxacin, a synthetic quinolone antibiotic, highlighting its spectrum of activity, bactericidal mechanisms, and methodological rigor. The research establishes Cinoxacin as a comparative benchmark for gram-negative infection and antibiotic resistance investigations, with practical implications for urinary tract infection models.

• Entinostat (MS-275): Optimizing Cancer Cell Assays & Protoco

  2026-05-20

  Entinostat (MS-275) empowers researchers to dissect HDAC-mediated pathways, enabling robust cancer cell proliferation inhibition and apoptosis studies. This guide translates recent reference study innovations into actionable workflows, troubleshooting strategies, and comparative insights for applied oncology research.

• WNT5a/GSK3/β-catenin Axis Modulates FAP Adipogenesis in Musc

  2026-05-19

  This study identifies the WNT5a/GSK3/β-catenin signaling axis as a central regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). Through integrated pharmacological, cytometric, and transcriptomic approaches, the research highlights new mechanisms to control pathological fat infiltration in myopathies and offers strategic insights for muscle degeneration research.

• Nystatin (Fungicidin): Polyene Antifungal Benchmarks & Use

  2026-05-19

  Nystatin (Fungicidin) is a polyene antifungal agent with potent action against Candida and Aspergillus species. Its mechanism centers on ergosterol binding, disrupting fungal membranes and leading to cell death. Quantitative benchmarks and validated research workflows underpin its role in antifungal studies.

• Targeted Amikacin Delivery into Granulomas: Dendritic Cell A

  2026-05-18

  This study demonstrates a novel strategy to deliver Amikacin directly into mycobacterial granulomas using dendritic cells as carriers. The approach enhances local antibiotic concentration at infection sites, potentially reducing systemic toxicity and improving the management of non-tuberculous mycobacterial infections.

• Cinoxacin (SKU BA1045): Reliable Solutions for Gram-Negative

  2026-05-18

  This article provides a scenario-driven, evidence-based exploration of Cinoxacin (SKU BA1045), a quinolone antibiotic from APExBIO, as a robust tool for reproducible cell viability, proliferation, and cytotoxicity assays targeting Gram-negative bacteria. It addresses real laboratory challenges, protocol optimization, and vendor selection, supporting its practical utility in urinary tract infection and antibiotic resistance research.

• DiscoveryProbe Protease Inhibitor Library: Applied Workflows

  2026-05-17

  The DiscoveryProbe™ Protease Inhibitor Library empowers translational researchers to modulate protease activity with precision in high throughput and high content screening formats. This article unpacks advanced workflows, troubleshooting strategies, and domain-bridging insights, ensuring robust experimental outcomes in apoptosis, cancer, and infectious disease research.

• Mitochondrial Permeability Transition Pore Assay Kit: Applie

  2026-05-16

  Unlock robust, quantitative mitochondrial function analysis with the Mitochondrial Permeability Transition Pore Assay Kit. This stepwise guide highlights experimental workflows, optimization strategies, and real-world troubleshooting, drawing on evidence from cutting-edge studies and best practices for precise assessment of mitochondrial permeability transition in disease models.

451 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page